InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,368.88
(
0.19%
)
Post# of 20617
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Honeycomb777

Send PM Follow Ignore
Followers 105
Posts 20514
Boards Moderated 0
Alias Born 06/30/2012

Honeycomb777

Re: None

Tuesday, 07/19/2016 4:29:50 PM

Tuesday, July 19, 2016 4:29:50 PM

Post# of 20617
Can someone beat this up.... Where am I wrong?? Let's say a billion in sales for the entire OTC nasal market is a stretch. Let's say it's 700M. Let's not even factor in revenue from their 13 products and let's just say we capture a 30 percent market share over 18 months IF approval takes place. So that's about 200m in revenue divided by say 80m shares = 2.50 eps multiplied by a PE of 8 equals 20 bucks a share! Where did I mess up ?? Tia. Even subtracting cost of goods sold, shouldn't this fall between 10-20 per share?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up